AI LIFE SCIENCES INVESTMENTS
AI LIFE SCIENCES INVESTMENTS
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-04-21 | MyndYou | AI Life Sciences Investments investment in Series A - MyndYou | 4 M USD |
| 2020-01-31 | Syndax Pharmaceuticals | AI Life Sciences Investments investment in Post-IPO Debt - Syndax Pharmaceuticals | 30 M USD |
| 2018-01-17 | SchoolCare | AI Life Sciences Investments investment in Series B - SchoolCare | 16 M USD |
More informations about "AI Life Sciences Investments"
AI Life Sciences Investments LLC - Crunchbase
AI Life Sciences Investments is a venture capital firm specializing in investments across various stages of company growth focusing on sectors like healthcare, SaaS, TMT, and technology. It …See details»
AI Life Sciences Investments investment portfolio - PitchBook
Dec 4, 2017 AI Life Sciences Investments's latest investment was on 22-Nov-2023 in Cortex (Healthcare Technology Systems), a company within the Outcome Management (Healthcare) …See details»
AI Life Sciences Investments LLC - Crunchbase
Dec 7, 2023 AI Life Sciences Investments LLC has made 4 investments. Their most recent investment was on Dec 7, 2023, when Cortex raised. $90M. How many investments has this …See details»
Making the most of life sciences investments in GenAI | EY - US
Nov 11, 2024 A s generative AI (GenAI) redefines the boundaries of innovation, chief information officers (CIOs) are leading their organizations’ efforts to harness the technology’s …See details»
Generative AI in life sciences: 2024 perspectives and …
Dec 7, 2023 ZS’s survey of tech execs in life sciences shows ambitious data, digital and AI investments, with generative AI now capturing the C-suite's imagination. Insights Insights. Expertise and perspectives to create impact …See details»
Generative AI in the pharmaceutical industry | McKinsey
Jan 9, 2024 Finally, we scaled the impact to the life-science industry, basing our estimates on the percentage of domain operating costs spent on tasks related to a generative AI use case (for example, the percentage of life-science R&D …See details»
10 new trends in life sciences analytics & digital
Jan 31, 2023 Analytics rule the world of life sciences tech investments. Life sciences companies make 45 percent of their tech investments in three analytics-related technologies —applied artificial intelligence (AI), industrialized …See details»
Artificial Intelligence in Life Sciences | Deloitte US
Artificial intelligence is a key next step in the evolution of life sciences companies and the Future of Health.â„¢ AI-enabled applications, machine learning, and advanced analytics capabilities are already helping companies thrive—and …See details»
Realizing Transformative Value from AI & Generative AI in Life …
$5-7 billion (Bn) dollars in value from the use of artificial intelligence (AI). We estimate that nearly 90% of value will be derived from three functional areas: research and development (R&D), …See details»
2023 KPMG US Life Sciences Sector Insights Report
Among companies in all sectors that have seen an increase in profitability or performance from their investments in data and analytics, life sciences companies are notably more likely to have experienced improvements in innovation (55 …See details»
Canada to drive billions in investments to build domestic AI
2 days ago Canada ranks third in the G7 in total funding per capita raised for AI companies, with more than 670 Canadian AI start-ups and 30 Canadian generative AI companies receiving at …See details»
2024 Outlook for Life Sciences | Deloitte US - Deloitte …
Dec 6, 2023 According to results from our Medtech Digital Innovation survey, more than 80% of medtech leaders said their organization’s largest digital investments were going toward AI. The economy and inflation: Last year, half …See details»
Chasing AI’s value in life sciences | MIT Technology Review
Oct 31, 2024 Inspired by an unprecedented opportunity, the life sciences sector has gone all in on AI. For example, in 2023, Pfizer introduced an internal generative AI platform expected to …See details»
AI startups in life sciences: Investment landscape | Netscribes
As organizations in the life sciences industry look to opportunities to generate greater returns and increase efficiencies, there’s a growing interest in AI-driven R&D processes among other …See details»
AI: Accelerating innovation in Life Sciences - CBRE
Oct 17, 2024 McKinsey also recently included life sciences as one of the top three industries that could achieve the biggest financial benefits from gen AI, quantifying the gains as 2.6-4.5% of revenue or $60 – $110bn annually. They identified the greatest value potential areas to be within the Commercial and R&D functions, but quantified benefits across the entire value chain.See details»
EU AI Act: How life sciences companies can prepare | ZS
Apr 16, 2024 With the March 13 passage of the EU’s AI Act, the world gets its first comprehensive set of regulations governing the use of artificial intelligence (AI)—and with it, …See details»
AI in life sciences R&D: The startup landscape | Netscribes
Jul 14, 2021 In the first half of 2021, investments flooded into AI in life sciences R&D startups, with their funding increasing by almost 3x compared to the same period in 2020. The startup landscape raked in USD 2.5B (H1 2021). Three major IPOs in this space have already taken place in 2021, including Adgene, Valo Health, and Recursion Pharmaceuticals. ...See details»
2024 Healthcare and Life Sciences Predictions
Jan 8, 2024 In 2024, we’ll learn more about the regulatory guardrails for healthcare and biomedical AI––such as the notion of nationwide healthcare AI assurance labs ––and we’ll …See details»
2024 CIO Survey Reveals IT Budgets AI Priorities For Life Sciences ...
Apr 9, 2024 One report shows that the life sciences market size for AI investment is expected to reach nearly $10 billion before 2032. 5 We’ve already seen pharma giants like Novo Nordisk …See details»
Gen AI in life sciences: Regulations and global clarity
Gen AI in life sciences and the potential role of global guardrails. Use of AI and gen AI in the life sciences industry, if used boldly, can revolutionize work production and be “a catalyst to a …See details»